Hyperlipidemia

• CLINICAL_TRIALS trial_result · 2006-12-04
  Clinical Trial Update: Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese(MEGA Study) [Phase 4]

  MEGA Study is a phase 4 trial in Japanese adults evaluating management of elevated cholesterol for primary prevention; the study status is c…

• CLINICAL_TRIALS trial_result · 2006-11-07
  Clinical Trial Update: The Clinical Evaluation of Efficacy of Lipid-Lowing Tea on Hyperlipidemia Patients' Lipid Profiles [Phase 3]

  A Phase 3 clinical trial is evaluating the efficacy of a lipid-lowering tea in hyperlipidemia patients. The current status of the study is u…

• CLINICAL_TRIALS trial_result · 2006-10-27
  Clinical Trial Update: Federal Study of Adherence to Medications in the Elderly (FAME) [NA]

  This is a completed clinical trial (FAME) investigating medication adherence in elderly patients with hypertension and hyperlipidemia.

• CLINICAL_TRIALS trial_result · 2006-09-11
  Clinical Trial Update: Integrating Family Medicine and Pharmacy to Advance Primary Care Therapeutics [Phase 4]

  A Phase 4 clinical trial evaluating integration of family medicine and pharmacy to advance primary care therapeutics has completed.

• CLINICAL_TRIALS trial_result · 2006-08-17
  Clinical Trial Update: Statin Therapy Vs. Therapeutic Lifestyle Changes and Supplements [NA]

  A completed clinical trial comparing statin therapy against therapeutic lifestyle changes and supplements for hyperlipidemia.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2006-06-28
  Clinical Trial Update: Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care [Phase 4]

  Phase 4 efficacy trial comparing Extended-Release Niacin/Lovastatin to usual care in patients with lipid disorders. The study has completed.

• CLINICAL_TRIALS trial_result · 2006-06-09
  Clinical Trial Update: Pravastatin for Hyperlipidaemia in HIV. [Phase 4]

  A Phase 4 clinical trial evaluating pravastatin for hyperlipidemia in HIV-infected individuals has completed.